Trastuzumab-Anns 63552-0270
Product NDC
63552-0270- Manufacturer
- Patheon Manufacturing Services Llc
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- August 2, 2022
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Trastuzumab | 420 mg/20mL |
Packaging Options(1)
80 VIAL, MULTI-DOSE in 1 TRAY (63552-270-00) / 20 mL in 1 VIAL, MULTI-DOSE